Vericel VCEL
NASDAQ VCEL
$40.19 -0.28 (-0.69%)
As of: Sep 4, 2026 · 3:59 PM EDT

Vericel (VCEL) Acquisitions (2014 - 2019)

Vericel (VCEL) posted Acquisitions of $13.9 million for Q3 2019, down 35.99% sequentially from $21.7 million in Q2 2019, and down 68.75% YoY from $44.5 million in Q3 2018.

Analysis

Vericel (VCEL) Acquisitions (2014 - 2019) Analysis & Trends

Vericel has reported Acquisitions for 6 years, with the latest figure at $13.9 million in Q3 2019.

  • Quarterly Acquisitions fell 68.75% year-over-year to $13.9 million in Q3 2019, while the trailing twelve-month figure through Sep 2019 was $90.8 million (up 105.36% YoY) and the FY2014 annual result came in at $1.4 million, changed N/A from the prior year.
  • Acquisitions declined to $13.9 million in Q3 2019 per VCEL's latest filing, from $21.7 million in the prior quarter.
  • Over five years, Acquisitions peaked at $44.5 million in Q3 2018 and troughed at -$2.3 million in Q4 2015.
  • A 5-year average of $6.1 million and a median of $353000.0 in 2015 frame the typical range for Acquisitions.
  • The sharpest annual moves came in 2017 and 2018: Acquisitions tumbled 213.75% in 2017, then jumped 16393.04% in 2018.
  • Over 5 years, Acquisitions stood at -$2.3 million in 2015, then soared by 43.61% to -$1.3 million in 2016, then soared by 79.22% to -$273000.0 in 2017, then surged by 16393.04% to $44.5 million in 2018, then sank by 68.75% to $13.9 million in 2019.
  • According to Business Quant data, Acquisitions over the past three periods registered $13.9 million, $21.7 million, and $10.7 million for Q3 2019, Q2 2019, and Q1 2019 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -
10 Vericel 2.05 Bn 1.89 Bn 56.40 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2019 13.90 Mn
Jun 30, 2019 21.72 Mn
Mar 31, 2019 10.69 Mn
Sep 30, 2018 44.48 Mn
Sep 30, 2017 -273,000.00
Jun 30, 2017 203,000.00
Mar 31, 2017 70,000.00
Dec 31, 2016 -1.31 Mn
Sep 30, 2016 240,000.00
Jun 30, 2016 1.06 Mn
Mar 31, 2016 13,000.00
Dec 31, 2015 -2.33 Mn
Sep 30, 2015 775,000.00
Jun 30, 2015 1.20 Mn
Mar 31, 2015 353,000.00
Sep 30, 2014 2.50 Mn
Jun 30, 2014 -1.05 Mn